Allogene Therapeutics shares are trading lower after the company announced its CFO Eric Schmidt will step down from his position.
Portfolio Pulse from Benzinga Newsdesk
Allogene Therapeutics announced that CFO Eric Schmidt will step down from his position, causing the company's shares to trade lower.
June 14, 2023 | 5:41 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Allogene Therapeutics shares are trading lower after the announcement of CFO Eric Schmidt's departure.
The departure of a key executive like the CFO can create uncertainty and impact investor confidence in the company. This news has led to a decline in Allogene Therapeutics' share price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100